Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Accounts Payables (2020 - 2026)

Journey Medical filings provide 6 years of Accounts Payables readings, the most recent being $8.9 million for Q4 2025.

  • On a quarterly basis, Accounts Payables fell 44.85% to $8.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $8.9 million, a 44.85% decrease, with the full-year FY2025 number at $8.9 million, down 44.85% from a year prior.
  • Accounts Payables hit $8.9 million in Q4 2025 for Journey Medical, down from $11.6 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $36.6 million in Q4 2022 to a low of $74000.0 in Q3 2022.
  • Median Accounts Payables over the past 5 years was $15.0 million (2024), compared with a mean of $15.6 million.
  • Biggest five-year swings in Accounts Payables: plummeted 87.67% in 2022 and later skyrocketed 37959.46% in 2023.
  • Journey Medical's Accounts Payables stood at $22.8 million in 2021, then soared by 60.31% to $36.6 million in 2022, then tumbled by 50.37% to $18.1 million in 2023, then dropped by 11.57% to $16.0 million in 2024, then crashed by 44.85% to $8.9 million in 2025.
  • The last three reported values for Accounts Payables were $8.9 million (Q4 2025), $11.6 million (Q3 2025), and $12.8 million (Q2 2025) per Business Quant data.